Literature DB >> 22434858

Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.

Lawrence Toll1, Karolina Pajak, Anita Plazinska, Krzysztof Jozwiak, Lucita Jimenez, Joseph A Kozocas, Mary J Tanga, James E Bupp, Irving W Wainer.   

Abstract

G protein-coupled receptors (GPCRs) are integral membrane proteins that change conformation after ligand binding so that they can transduce signals from an extracellular ligand to a variety of intracellular components. The detailed interaction of a molecule with a G protein-coupled receptor is a complicated process that is influenced by the receptor conformation, thermodynamics, and ligand conformation and stereoisomeric configuration. To better understand the molecular interactions of fenoterol analogs with the β(2)-adrenergic receptor, we developed a new agonist radioligand for binding assays. [(3)H](R,R')-methoxyfenoterol was used to probe the binding affinity for a series of fenoterol stereoisomers and derivatives. The results suggest that the radioligand binds with high affinity to an agonist conformation of the receptor, which represents approximately 25% of the total β(2)-adrenoceptor (AR) population as determined with the antagonist [(3)H]CGP-12177. The β(2)-AR agonists tested in this study have considerably higher affinity for the agonist conformation of the receptor, and K(i) values determined for fenoterol analogs model much better the cAMP activity of the β(2)-AR elicited by these ligands. The thermodynamics of binding are also different when interacting with an agonist conformation, being purely entropy-driven for each fenoterol isomer, rather than a mixture of entropy and enthalpy when the fenoterol isomers binding was determined using [(3)H]CGP-12177. Finally, computational modeling identified the molecular interactions involved in agonist binding and allow for the prediction of additional novel β(2)-AR agonists. The study underlines the possibility of using defined radioligand structure to probe a specific conformation of such shape-shifting system as the β(2)-adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434858      PMCID: PMC3362895          DOI: 10.1124/mol.111.077347

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  29 in total

1.  Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells.

Authors:  C Hoffmann; M R Leitz; S Oberdorf-Maass; M J Lohse; K-N Klotz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-17       Impact factor: 3.000

2.  {Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells.

Authors:  L Toll; L Jimenez; N Waleh; K Jozwiak; A Y-H Woo; R-P Xiao; M Bernier; I W Wainer
Journal:  J Pharmacol Exp Ther       Date:  2010-11-11       Impact factor: 4.030

3.  The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.

Authors:  Jillian G Baker
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 4.  Can thermodynamic measurements of receptor binding yield information on drug affinity and efficacy?

Authors:  P A Borea; A Dalpiaz; K Varani; P Gilli; G Gilli
Journal:  Biochem Pharmacol       Date:  2000-12-01       Impact factor: 5.858

5.  Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states.

Authors:  Gayathri Swaminath; Yang Xiang; Tae Weon Lee; Jacqueline Steenhuis; Charles Parnot; Brian K Kobilka
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

6.  Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors.

Authors:  Stefania Merighi; Carolina Simioni; Stefania Gessi; Katia Varani; Pier Andrea Borea
Journal:  Biochem Pharmacol       Date:  2009-09-18       Impact factor: 5.858

7.  Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding.

Authors:  O E Brodde; K Karad; H R Zerkowski; N Rohm; J C Reidemeister
Journal:  Circ Res       Date:  1983-12       Impact factor: 17.367

8.  High affinity [3H]formoterol binding sites in lung: characterization and autoradiographic mapping.

Authors:  J C Mak; B Grandordy; P J Barnes
Journal:  Eur J Pharmacol       Date:  1994-09-15       Impact factor: 4.432

9.  Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.

Authors:  Krzysztof Jozwiak; Chakir Khalid; Mary J Tanga; Ilona Berzetei-Gurske; Lucita Jimenez; Joseph A Kozocas; Anthony Woo; Weizhong Zhu; Rui-Ping Xiao; Darrell R Abernethy; Irving W Wainer
Journal:  J Med Chem       Date:  2007-05-17       Impact factor: 7.446

10.  Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor.

Authors:  Michael P Bokoch; Yaozhong Zou; Søren G F Rasmussen; Corey W Liu; Rie Nygaard; Daniel M Rosenbaum; Juan José Fung; Hee-Jung Choi; Foon Sun Thian; Tong Sun Kobilka; Joseph D Puglisi; William I Weis; Leonardo Pardo; R Scott Prosser; Luciano Mueller; Brian K Kobilka
Journal:  Nature       Date:  2010-01-07       Impact factor: 49.962

View more
  6 in total

1.  Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.

Authors:  Michael T Reinartz; Solveig Kälble; Irving W Wainer; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-31       Impact factor: 3.000

2.  Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.

Authors:  Seungkirl Ahn; Alem W Kahsai; Biswaranjan Pani; Qin-Ting Wang; Shuai Zhao; Alissa L Wall; Ryan T Strachan; Dean P Staus; Laura M Wingler; Lillian D Sun; Justine Sinnaeve; Minjung Choi; Ted Cho; Thomas T Xu; Gwenn M Hansen; Michael B Burnett; Jane E Lamerdin; Daniel L Bassoni; Bryant J Gavino; Gitte Husemoen; Eva K Olsen; Thomas Franch; Stefano Costanzi; Xin Chen; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-27       Impact factor: 11.205

3.  Regulation of β2-adrenergic receptor function by conformationally selective single-domain intrabodies.

Authors:  Dean P Staus; Laura M Wingler; Ryan T Strachan; Soren G F Rasmussen; Els Pardon; Seungkirl Ahn; Jan Steyaert; Brian K Kobilka; Robert J Lefkowitz
Journal:  Mol Pharmacol       Date:  2013-12-06       Impact factor: 4.436

4.  Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β₂-adrenergic receptor.

Authors:  Anita Plazinska; Karolina Pajak; Ewelina Rutkowska; Lucita Jimenez; Joseph Kozocas; Gary Koolpe; Mary Tanga; Lawrence Toll; Irving W Wainer; Krzysztof Jozwiak
Journal:  Bioorg Med Chem       Date:  2013-11-23       Impact factor: 3.641

5.  Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.

Authors:  Anita Plazinska; Wojciech Plazinski; Krzysztof Jozwiak
Journal:  Eur Biophys J       Date:  2015-03-01       Impact factor: 1.733

6.  Small-Molecule Positive Allosteric Modulators of the β2-Adrenoceptor Isolated from DNA-Encoded Libraries.

Authors:  Seungkirl Ahn; Biswaranjan Pani; Alem W Kahsai; Eva K Olsen; Gitte Husemoen; Mikkel Vestergaard; Lei Jin; Shuai Zhao; Laura M Wingler; Paula K Rambarat; Rishabh K Simhal; Thomas T Xu; Lillian D Sun; Paul J Shim; Dean P Staus; Li-Yin Huang; Thomas Franch; Xin Chen; Robert J Lefkowitz
Journal:  Mol Pharmacol       Date:  2018-05-16       Impact factor: 4.436

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.